Graft-versus-host disease: pathophysiological and clinical aspects

Annual Review of Medicine
H J Deeg, R Storb

Abstract

Graft-versus-host disease (GVHD) is a syndrome observed after allogeneic marrow transplantation and presumably mediated by donor T lymphocytes reactive against the tissues of the recipient. Clinically relevant acute GVHD develops in 35-50% of patients given HLA-identical marrow grafts within the first 100 days of transplantation. The main target organs are skin, liver, and intestinal tract. Approximately one half of the patients with moderately severe to severe disease die, usually from associated infections. Prevention of acute GVHD by placing the patient in protective isolation, immunosuppressive treatment after grafting, or removal of donor lymphocytes from the marrow inoculum has, as yet, not been uniformly successful. Treatment of established GVHD involves the use of immunosuppressants such as glucocorticosteroids, antithymocyte globulin, cyclosporine, and monoclonal antibodies. Chronic GVHD usually develops 100-500 days after transplantation and affects about 45% of all long-term survivors. The main target organs are the same as those of acute GVHD and, in addition, lacrimal and salivary glands, and mucous and serous membranes; the clinical picture resembles that of a number of collagen-vascular diseases. The incidence of...Continue Reading

Citations

Nov 1, 1993·Cancer Immunology, Immunotherapy : CII·U N Verma, A Mazumder
Jun 25, 2008·Bone Marrow Transplantation·E CaloreChiara Messina
Dec 27, 1995·Transplantation·R ShapiroF Egidi
Jun 7, 2013·Science Translational Medicine·Benjamin G Vincent, Jonathan S Serody
Mar 5, 2003·Annual Review of Immunology·Motonari KondoIrving L Weissman
Jun 8, 2001·The Journal of Clinical Investigation·T KuroiwaT Iwasaki
Nov 6, 2013·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Tsuyoshi Iwasaki, Seiji Shibasaki
Jun 3, 2005·Clinical Medicine & Research·Tsuyoshi Iwasaki
Oct 29, 2011·Neurologic Clinics·Rajat Dhar, Theresa Human
Mar 1, 1988·Transfusion Medicine Reviews·S J Slichter
Apr 21, 2009·Microbes and Infection·Jens LohrAbul K Abbas
Dec 16, 2004·Acta Clinica Belgica·E SteelsM Heenen
Jun 28, 2013·Journal of Cellular and Molecular Medicine·Liren QianJianliang Shen
Aug 1, 1991·Clinical Biochemistry·M J Cowan
Nov 16, 2004·Journal of Immunological Methods·Brigitte KircherE Goulmy
Jun 1, 1984·British Journal of Haematology·H J DeegE D Thomas
Feb 16, 2007·Pediatric Transplantation·B KuskonmazD Uckan
Oct 28, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Li-Ru WangDao-Pei Lu
Apr 1, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nathan CantoniM Stern
Apr 1, 1990·Baillière's Clinical Rheumatology·C M Black
Jan 5, 2005·Journal of Hepatology·Jesús MedinaRicardo Moreno-Otero
Feb 1, 1990·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·P L KaprothE P Shronts
Feb 1, 1993·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·V M Herrmann, P J Petruska
Oct 21, 2000·Bone Marrow Transplantation·K S BakerB R Blazar
Aug 17, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·George V MazariegosJorge Reyes
Nov 12, 2002·Medical and Pediatric Oncology·Guido LuzzattoLuigi Zanesco
Jun 2, 1998·Journal of Computer Assisted Tomography·N TomuraG Takada
Feb 16, 2000·Bone Marrow Transplantation·J P WoodardK S Baker
Jan 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G Alexander, B Portmann
Jul 1, 1986·International Journal of Cell Cloning·O Prümmer, T M Fliedner
Apr 1, 1987·The Journal of Pathology·V J Desmet, K Geboes
Jul 25, 2006·Blood·Moniek A de WitteTon N M Schumacher
Jan 30, 2002·The American Journal of Clinical Nutrition·Maurizio MuscaritoliFilippo Rossi Fanelli
Jan 1, 1987·Pharmacotherapy·G C Yee
Jul 27, 2000·Scandinavian Journal of Gastroenterology·M H WangC Y Wang
Oct 21, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel H KaplanWarren D Shlomchik
Jun 1, 1987·Journal of the Royal Society of Medicine·A J Barrett
Oct 8, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laurence QuéméneurJacqueline Marvel
Nov 19, 1990·The Medical Journal of Australia·M R VowelsR Brown

Related Concepts

Hypoplastic Anemia
Graft-vs-Host Disease
Natural Immunosuppression
Leukemia
Methotrexate, (DL)-Isomer
Patient Isolation
T-Lymphocyte
Transplantation, Homologous
Bone Marrow Cell Transplantation

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.